Authors: Schwenger, V Mussig, C Hergesell, O Zeier, M Ritz, E

Citation: V. Schwenger et al., Incidence and clinical presentation of terminal renal failure in diabetic patients, DEUT MED WO, 126(47), 2001, pp. 1322-1326

Authors: Ritz, E Hergesell, O

Citation: E. Ritz et O. Hergesell, Tumour-like calcinosis causing reversible tetraparesis in a patient on continuous ambulatory peritoneal dialysis, NEPH DIAL T, 16(9), 2001, pp. 1958-1958

Authors: Nowack, R Gobel, U Klooker, P Hergesell, O Andrassy, K Van der Woude, FJ

Citation: R. Nowack et al., Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement, J AM S NEPH, 10(9), 1999, pp. 1965-1971

Authors: Henle, T Deppisch, R Beck, W Hergesell, O Hansch, GM Ritz, E

Citation: T. Henle et al., Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds, NEPH DIAL T, 14(8), 1999, pp. 1968-1975

Authors: Hergesell, O Ritz, E

Citation: O. Hergesell et E. Ritz, Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients, NEPH DIAL T, 14(4), 1999, pp. 863-867

Authors: Hergesell, O Ritz, E

Citation: O. Hergesell et E. Ritz, Phosphate binders on iron basis: A new perspective?, KIDNEY INT, 56, 1999, pp. S42-S45